The single-use assemblies market has seen considerable growth due to a variety of factors.
• The market size for single-use assemblies has seen a rapid expansion over the recent past. Projected growth indicates an increase from $6.12 billion in 2024 to $7.48 billion in 2025, reflecting a compound annual growth rate (CAGR) of 22.1%.
Factors contributing to this upward trend in the historical phase include biopharmaceutical production, versatility and cost effectiveness, diminished risk of cross-contamination, adherence to regulatory standards in biomanufacturing, and the heightened demand for modular and plug-and-play systems.
The single-use assemblies market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of single-use assemblies is predicted to witness remarkable growth in the coming years, reaching a valuation of $17.3 billion by 2029 with a compound annual growth rate of 23.3%.
The predicted rise during the forecast period is due to the expansion of personalized medicine, gene and cell therapy production, adoption of continuous biomanufacturing, modular and flexible biomanufacturing facilities, the emergence of new markets and global biomanufacturing hubs, and single-use manufacturing for vaccine production. Key trends during the forecast period are anticipated to include the integration of advanced sensors in single-use assemblies, the use of IoT and data analytics for bioprocess monitoring, automation and robotization of single-use systems, disposable chromatography columns and membranes, single-use tangential flow filtration (tff) systems, and the scaling and standardization of single-use processes.
The expansion of single-use assemblies is anticipated to be fueled by a growing demand for biopharmaceuticals and an uptick in life science research and development. State-of-the-art biotechnological methods are commonly used in the production of biopharmaceuticals, which are complex medicines derived from living cells or organisms. These single-use systems are a key part of biopharmaceutical manufacturing. Furthermore, elevated investment in life science research contributes to the creation of new drugs. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based group representing the pharmaceutical industry, reported in June 2023, significant growth in European pharmaceutical production, with industry worth escalating from $352.48 billion in 2021 to $369.95 billion in 2022. Consequently, single-use assemblies' growth is being prompted by an amplified demand for biopharmaceuticals and a surge in life science research and development.
The single-use assemblies market covered in this report is segmented –
1) By Product Type: Filtration Assemblies, Bag Assemblies, Bottle Assemblies, Mixing System Assemblies
2) By Solution: Standard Solutions, Customized Solutions
3) By Application: Cell Culture And Mixing, Filtration, Storage, Sampling, Fill-Finish application
4) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research And Contract Manufacturing Organizations, Academic And Research Institutes
Subsegments:
1) By Filtration Assemblies: Capsule Filters, Inline Filters, Filter Holders
2) By Bag Assemblies: Single-Use Bags with Tubing, Bioprocessing Bags, Transfer Bags
3) By Bottle Assemblies: Single-Use Bottles with Tubing, Sterile Bottles, Sample Collection Bottles
4) By Mixing System Assemblies: Single-Use Mixing Bags, Agitation Systems, Pre-Configured Mixing Solutions
Leading companies in the single-use assemblies market are sustaining their market stand by introducing sophisticated technology such as the filling assembly. This system is tailored to dispense and package liquid or semi-liquid items into vessels efficiently and accurately, which ensures accurate specifications and reduces contamination. For instance, in April 2024, SaniSure a United States based maker of single-use systems and fittings, introduced Fill4Sure, a personalized single-use filling assembly intended to expedite drug market penetration while enhancing safety, efficiency, and consistency in drug product filling. Fill4Sure provides solutions to key challenges in the fill-finish process like excessive costs and sluggish speeds, by providing cost-effective, customizable assemblies that can be easily scaled to match industry requirements. Elements like low-particulate 2D surge bags, sturdy silicone over molding, high-performance tubing for precision, and contamination-free needles, all contribute to streamline biomanufacturing procedures and boost supply chain dependability.
Major companies operating in the single-use assemblies market include:
• Avantor Inc.
• Corning Incorporated
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Merck KGaA
• Entegris Inc.
• KUHNER AG
• Lonza Group Ltd.
• Saint-Gobain India Pvt. Ltd.
• Parker Hannifin Corporation
• Repligen Corporation
• Meissner Filtration Products
• NewAge Industries Inc.
• Antylia Scientific
• Romynox B.V
• Global Life Sciences Solutions USA
• Wego Pharmaceutical
• Eppendorf AG
• Finesse Solutions
• GE Healthcare Life Sciences
• GEA Group AG
• Infors AG
• MilliporeSigma
• Pall Corporation
• PendoTECH
• SaniSure Inc.
• Keofitt A/S
• Intellitech Inc.
• Dover Corporation
• Foxx Life Sciences
• TSE Industries Inc.
• Fujimori Kogyo Co. Ltd.
• Compagnie Générale des Établissements Michelin
• Cellexus Ltd.
• Fluid Flow Products Inc.
North America was the largest region in the single-use assemblies market in 2024. The regions covered in the single-use assemblies market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.